BRIEF-Scancell updates on clinical trial
LONDON Jan 29 (Reuters) - Scancell Holdings PLC : * update on patient recruitment in clinical trial * treats final patient in the second part of its Phase 1/2 clinical trial of SCIB1,its DNA ImmunoBody vaccine being developed for the treatment of melanoma.
- Tweet this
- Share this
- Digg this